Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tenet HealthcareMEX:THC 78 3-Year EBITDA Growth Rate is 21.00% as of Jun. 2026, which is 139% above its 10-year median of 8.80. GuruFocus rates MEX:THC with a GF Score™ of 78/100 and a GF Value™ of MXN2,552.92. The stock has 5 warning signs investors should review. Among 525 Healthcare Providers & Services companies, Tenet Healthcare ranks better than 67.24% on this metric.
During the past 12 months, Tenet Healthcare's average EBITDA Per Share Growth Rate was 32.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 21.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 18.70% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 11.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Tenet Healthcare was 38.50% per year. The lowest was -50.20% per year. And the median was 8.80% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Tenet Healthcare 3-Year EBITDA Growth Rate Related Terms
MEX:THC vs DVA, EHC, ENSG: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Tenet Healthcare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tenet Healthcare 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tenet Healthcare's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Tenet Healthcare's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 21.00% mean?
Tenet Healthcare (MEX:THC) has a 3-Year EBITDA Growth Rate of 21.00% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Tenet Healthcare and its competitors. This is 139% above median its historical median of 8.80. According to the industry distribution chart, Tenet Healthcare ranks #172 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 32.8%.
Is Tenet Healthcare's 3-Year EBITDA Growth Rate too high?
Tenet Healthcare's current 3-Year EBITDA Growth Rate of 21.00% is 139% above median its 10-year median of 8.80. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Tenet Healthcare's value of 21.00% is 105.9% above this industry median. Based on the distribution chart, Tenet Healthcare ranks #172 out of 525 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Tenet Healthcare has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Tenet Healthcare's 3-Year EBITDA Growth Rate compare to DVA and EHC?
According to the Healthcare Providers & Services industry distribution chart, Tenet Healthcare ranks #172 out of 525 companies for 3-Year EBITDA Growth Rate. This puts Tenet Healthcare in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. Tenet Healthcare's value of 21.00% is 105.9% above this benchmark. While the company's 10-year median is 8.80 vs. the industry median of 10.20, Tenet Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tenet Healthcare's current 3-Year EBITDA Growth Rate of 21.00% is 105.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Tenet Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tenet Healthcare's current 3-Year EBITDA Growth Rate is 21.00%, which is 139% above median its own 10-year median of 8.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenet Healthcare stock overvalued right now?
Tenet Healthcare (MEX:THC) has a current 3-Year EBITDA Growth Rate of 21.00%. The stock's GF Value™ is MXN2,552.92, compared to a current price of MXN3,547.50 — trading 39% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 21.00%, which is 139% above median its 10-year median of 8.80 and 105.9% above the Healthcare Providers & Services industry median of 10.20. Tenet Healthcare's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Tenet Healthcare (MEX:THC), the current 3-Year EBITDA Growth Rate is 21.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tenet Healthcare (MEX:THC) Overvalued in 2026?
Based on GuruFocus' analysis, Tenet Healthcare stock appears to be overvalued.
The current stock price of MXN3,547.50 is trading 39% above its estimated GF Value™ of MXN2,552.92.
Key valuation signals for MEX:THC:
3-Year EBITDA Growth Rate: 21.00% (139% above median its 10-year median of 8.80)
GF Value™: MXN2,552.92 vs. price of MXN3,547.50 (39% above fair value)
Industry Position: 105.9% above the Healthcare Providers & Services median (#172 of 525)
No single metric tells the full story. See the MEX:THC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
78GF Score
Get the complete analysis for MEX:THC
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:THC has been successfully added to your 
